
WASHINGTON, Aug. 17 (UPI) -- The U.S. Food and Drug Administration announced the recall of a Barr Laboratories Inc. amphetamine product because of a health hazard.
The FDA said the dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate 20mg mixed amphetamine salt tablets are being recalled because some might exceed weight requirements, resulting in super-potency.
The federal agency said potential adverse reactions to a supratherapeutic dose could include cardiovascular, neurologic, psychiatric and gastrointestinal reactions such as: palpitations, euphoria, tachycardia, hypertension, headache, tremor, anxiety and decreased appetite.
"This product can be uniquely identified as an oval peach colored tablet, debossed with "b/973" on one side and "2/0" on the other side," the FDA said, noting the company distributed the affected lot between June 11 and June 16. Only lot 311756 is affected by the recall.
Consumers with questions can call 888-742-5578.
|
|
|
| Additional Science News Stories | |
TACOMA, Wash., Feb. 9 (UPI) --
The mother of Josh Powell, who killed himself and his sons in a fire in Washington state, said in divorce papers he exhibited disturbing behavior as a teenager.
|
NEW YORK, Feb. 9 (UPI) --
Macaulay Culkin is in "perfectly good health," his publicist said after the former child star was photographed looking gaunt and disheveled in New York.
|
GREENBELT, Md., Feb. 9 (UPI) --
NASA's Mars Reconnaissance Orbiter has captured the first color image from orbit of the three-petal lander of NASA's 2004 Rover Spirit mission, scientists say.
|
XINXIANG CITY, China, Feb. 9 (UPI) --
A set of parents in China said they expected a large baby, but they were shocked when their son came out weighing a potentially record-setting 15 1/2 pounds.
|
| Stories | Photos | People | Comments |
View Caption